Conduit Pharmaceuticals (CDT) Q2 2024 Earnings

CDT·Reported August 12, 2024·Before market open

Diluted EPS came in at $-839.58.

Diluted EPS

$-839.58

SEC Filings

Earnings release8-K not filed yet

Quarterly report10-Q · 0001493152-24-031385

Financial Snapshot

Trailing eight quarters through Q2 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q2 2024 Earnings FAQ

Common questions about Conduit Pharmaceuticals's Q2 2024 earnings report.

Conduit Pharmaceuticals (CDT) reported Q2 2024 earnings on August 12, 2024 before market open.

Conduit Pharmaceuticals reported diluted EPS of $-839.58 for Q2 2024.

You can read the 10-Q periodic report (0001493152-24-031385) directly on SEC EDGAR. The filing index links above go to sec.gov.